Coexpression with IL-7R in CAR-T cells sustains signaling upon antigen recognition while sparing bystander lymphocytes, with early clinical trials (NCT04099797, NCT03635632) evaluating IL-7R-expressing GD2 CAR-T cells in brain tumors and refractory neuroblastoma [126]. The gene discussed is IL7R; the disease is brain neoplasm.